Clinical Trials Logo

Filter by:
NCT ID: NCT04889248 Completed - Clinical trials for Amyotrophic Lateral Sclerosis

Inspiratory Muscle Training With Powerbreath Device in Patients With ALS

Start date: May 17, 2021
Phase: N/A
Study type: Interventional

Abstract: Context/background: people affected by Amyotrophic Lateral Sclerosis (ALS) see their own life totally disturbed after the diagnosis. This disease also courses, apart from the functional and depressing worsening, with internal damage manifested by a cardio respiratory deterioration. There are not many clinical studies publications about this disease given that is considered a weird illness with short prognosis. Objectives: to examine the effects of the inspiratory muscle training (IMT) on respiratory muscle strength, heart rate variability (HRV), quality of life and mood in patients with ALS. Methods: 20 volunteer patients, male and female, with ALS, bulbar or spinal will take part of the cuasi-experimental study and they will be divided into two groups: an experimental group (n = 10) and a control group (n = 10). The Maximum Inspiratory Pressure (PIM), the HRV, the quality of life and mood will be measured. The participants of experimental group will conduct 30 inspirations per day, 15 in the morning and 15 in the evening, 5 days per week, through 8 weeks. The resistance of the training in the experimental group will be increase acording to the PIM measured at the first visit. During the first week, the resistance will be at 30% of PImax, weeks 2 and 3 at 40%, weeks 4 and 5 at 50% and the last 3 weeks at 60%. After 8 weeks, all participants will fill up again all scales and post training measurements will be taken.

NCT ID: NCT04889183 Completed - Obesity Clinical Trials

SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without Diabetes

SMART
Start date: March 14, 2022
Phase: Phase 3
Study type: Interventional

Study to assess the effects of weekly subcutaneous administration of the GLP1-RA semaglutide 2.4mg on kidney function parameters in obese/overweight individuals at high risk of CKD progression.

NCT ID: NCT04887506 Completed - Clinical trials for Metastatic Castration-resistant Prostate Cancer

TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer

Start date: May 5, 2021
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate the safety and efficacy of a new formulation of an existing drug product called TAVT-45 in patients with metastatic prostate cancer.

NCT ID: NCT04887220 Completed - Quality of Life Clinical Trials

Persistent Pain and Its Impact on Quality of Life COVID-19 Patients That Required Critical Care

Start date: February 15, 2021
Phase:
Study type: Observational

COVID-19 infection produces thousands of hospital admissions in a very short period of time, including critical care patients. It is expected that those who survive a severe spectrum of the disease, will present some degree of health decline in the medium and long term, becoming chronic patients. Post-intensive care syndrome (PICS) was described by the Society of Critical Care Medicine (SCCM) as a new altered or worsening of physical, cognitive, or mental condition due to critical illness and persisting after hospitalization, including pain. Also, clinical features of infection include different types of pain, and if this pain persists, it can turn into a chronic condition. Chronic pain is a currently recognized disease, but under-treated in many cases, generating a significant deterioration in the quality of life of this patient. It is vitally important to generate early care circuits to detect and treat those expected complications, such as chronic pain in these patients. The objective of this study is to estimate the level of persistent pain and its impact on health-related quality of life after admission to an intensive care unit in patients who suffered this infection.

NCT ID: NCT04885608 Completed - Frail Elderly Clinical Trials

PReGe in Outdoor Fitness Parks

PReGe-BIO
Start date: May 10, 2021
Phase: N/A
Study type: Interventional

Older people have been one of the most affected by the Covid-19 pandemic. Restrictive measures to prevent the spread of the virus have affected the lifestyle of older people, which have reduced their level of physical activity. A sedentary lifestyle has negative health consequences, such as increased frailty and decreased functional capacity. The aim of the study is to apply a program of therapeutic exercise in outdoor fitness parks to prevent the complications of sedentary lifestyle. Community-dwelling older adults belonging will participate in an outdoor program to keep security measures and prevent contagion.

NCT ID: NCT04884932 Completed - Neuromodulation Clinical Trials

Percutaneous High Frequency Alternating Current Stimulation in Healthy Volunteers With 30kHz

Start date: May 13, 2021
Phase: N/A
Study type: Interventional

High-frequency alternating currents of greater than 1 kHz applied on peripheral nerves has been used in animal studies to produce a motor nerve block. It has been evidenced that frequencies higher than 5 kHz are necessary to produce a complete peripheral nerve block in primates, whose nerve thickness is more similar to humans.

NCT ID: NCT04884828 Completed - Clinical trials for Non-invasive Ventilation

Asynchronies in NIV With External Gas

Start date: April 1, 2018
Phase:
Study type: Observational

NIV can be combined with other treatments that require to introduce gas into the circuit during the treatment. This external gas produces trigger asynchronies that worse depending on the model ventilator, trigger design and gas source. It is advisable to monitor NIV when these treatments are requiring in chronic NIV.

NCT ID: NCT04884438 Completed - Affect Clinical Trials

Intervention for the Promotion of Gratitude

Start date: October 1, 2021
Phase: N/A
Study type: Interventional

This study aims to analyze the effects of a psychological intervention to promote wellbeing. To do so, a brief intervention is developed to enhance a sense of gratitude through a multiple baseline across components design. Traditional measures will be used together with the incorporation of a novel evaluation methodology such as the EMA, which allows the collection of data in the context of people's daily lives and at different specific times, that is, in real time.

NCT ID: NCT04884191 Completed - Clinical trials for Primary Myelofibrosis

Phase 2 Study: An Open-Label, Randomized, Phase 2 Dose-Finding Study of Pacritinib in Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post- Essential Thrombocythemia Myelofibrosis Previously Treated With Ruxolitinib

Start date: July 31, 2017
Phase: Phase 2
Study type: Interventional

This was an open-label, randomized, dose-finding study in patients with primary or secondary MF (Dynamic International Prognostic Scoring System [DIPSS] risk score of Intermediate-1 to High-Risk) who were previously treated with ruxolitinib. The study was designed to support a pacritinib dosage selection decision with evaluation of 3 dosages.

NCT ID: NCT04883606 Completed - Clinical trials for Short Bowel Syndrome

A Study With Teduglutide (Revestive®) in Adults With Short Bowl Syndrome

T-Rex
Start date: January 26, 2022
Phase:
Study type: Observational

The main aims of the study are to assess the safety profile of teduglutide (Revestive®) as well as how many people with Short Bowl Syndrome experience a reduction of parenteral support when treated with teduglutide (Revestive®). This study is about collecting existing data only; participants will not receive teduglutide (Revestive®) as part of this study. No new information will be collected during this study. Only data already available in the hospital records will be reviewed and collected for this study. Participants do not need to visit their doctor in addition to their normal visits.